Synopsis
Synopsis
0
VMF
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. 3,5,3',5'-tetraiodothyronine
2. Berlthyrox
3. Dexnon
4. Eferox
5. Eltroxin
6. Eltroxine
7. Euthyrox
8. Eutirox
9. L Thyrox
10. L Thyroxin Beta
11. L Thyroxin Henning
12. L Thyroxine
13. L Thyroxine Roche
14. L-3,5,3',5'-tetraiodothyronine
15. L-thyrox
16. L-thyroxin Beta
17. L-thyroxin Henning
18. L-thyroxine
19. L-thyroxine Roche
20. Lvothyrox
21. Levo T
22. Levo-t
23. Levothroid
24. Levothyroid
25. Levothyroxin Deladande
26. Levothyroxin Delalande
27. Levothyroxine
28. Levothyroxine Sodium
29. Levoxine
30. Levoxyl
31. Novothyral
32. Novothyrox
33. O-(4-hydroxy-3,5-diiodophenyl) 3,5-diiodo-l-tyrosine
34. O-(4-hydroxy-3,5-diiodophenyl)-3,5-diiodotyrosine
35. Oroxine
36. Sodium Levothyroxine
37. Synthroid
38. Synthrox
39. T4 Thyroid Hormone
40. Thevier
41. Thyrax
42. Thyroid Hormone, T4
43. Thyroxin
44. Thyroxine
45. Tiroidine
46. Tiroxina Leo
47. Unithroid
1. 25416-65-3
2. Levothyroxine Sodium
3. L-thyroxine Sodium Xhydrate
4. Levothyroxine Sodium Hydrate
5. L-thyroxine Sodium Hydrate
6. Monosodium L-thyroxine Hydrate
7. 31178-59-3
8. Chebi:6447
9. Levothroid
10. Synthroid
11. Levothyrox
12. Levaxin
13. Levoxyl
14. Oroxine
15. Soloxine
16. Eferox
17. Sodium;(2s)-2-amino-3-[4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl]propanoate;hydrate
18. B82379r9w0
19. Thyroxine Sodium
20. Levo-t
21. Liotrix (t4)
22. Thyroxine Sodium Salt
23. L-tyrosine, O-(4-hydroxy-3,5-diiodophenyl)-3,5-diiodo-, Monosodium Salt, Monohydrate
24. Latequatro
25. Letequatro
26. Levoroxin
27. Levotiron
28. Tiroxina
29. Tivoral
30. Levo-tiroxina Glaxo
31. Nsc-259940
32. L-tyrosine, O-(4-hydroxy-3,5-diiodophenyl)-3,5-diiodo-, Monosodium Salt, Hydrate
33. Unii-b82379r9w0
34. Levothroid (tn)
35. Synthroid (tn)
36. Levoxyl (tn)
37. Levothyroxine Sodium [usp:inn:jan]
38. Starbld0009614
39. L-thyroxin Monosodium Salt
40. T4 (liotrix)
41. Levothyroxine Sodium (usp)
42. Schembl2327406
43. Chembl2103741
44. L-thyroxine Sodium Salt Monohydrate
45. 3,3',5,5'-tetraiodo-l-thyronine Monosodium Salt Hydrate
46. Levothyroxine Sodium Hydrate (jp17)
47. Mfcd06408007
48. Akos015895962
49. Ks-1237
50. D01010
51. E78443
52. Levothyroxine Sodium Monohydrate [who-ip]
53. 3,3',5,5'-tetraiodo-l-thyronine Monosodium Salt
54. A817851
55. Q27107209
56. Levothyroxinum Natricum Monohydrate [who-ip Latin]
57. Sodium 2-amino-3-[4-(4-hydroxy-3,5-diiodo-phenoxy)-3,5-diiodo-phenyl]propanoate Hydrate
58. Sodium (s)-2-amino-3-(4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl)propanoate Xhydrate
Molecular Weight | 816.87 g/mol |
---|---|
Molecular Formula | C15H12I4NNaO5 |
Hydrogen Bond Donor Count | 3 |
Hydrogen Bond Acceptor Count | 6 |
Rotatable Bond Count | 5 |
Exact Mass | 816.6792 g/mol |
Monoisotopic Mass | 816.6792 g/mol |
Topological Polar Surface Area | 96.6 Ų |
Heavy Atom Count | 26 |
Formal Charge | 0 |
Complexity | 426 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 1 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 3 |
1 of 8 | |
---|---|
Drug Name | Levo-t |
Drug Label | Levothyroxine sodium tablets, USP contains synthetic crystalline L-3,3',5,5'-tetraiodothyronine sodium salt [levothyroxine (T4) sodium]. Synthetic T4 is identical to that produced in the human thyroid gland.Levothyroxine (T4) sodium has an empir |
Active Ingredient | Levothyroxine sodium |
Dosage Form | Tablet |
Route | Oral |
Strength | 0.05mg **see current annual edition, 1.8 description of special situations, levothyroxine sodium; 0.112mg **see current annual edition, 1.8 description of special situations, levothyroxine sodium; 0.2mg **see current annual edition, 1.8 description of spe |
Market Status | Prescription |
Company | Alara Pharm |
2 of 8 | |
---|---|
Drug Name | Levothroid |
PubMed Health | Thyroid Supplement (By mouth) |
Drug Classes | Diagnostic Agent, Thyroid Function, Thyroid Supplement |
Drug Label | LEVOTHROID (levothyroxine sodium tablets, USP) contains synthetic crystalline L-3,3',5,5'-tetraiodothyronine sodium salt [levothyroxine (T4) sodium]. Synthetic T4 is identical to that produced in the human thyroid gland. Levothyroxine (T4) sodiu |
Active Ingredient | Levothyroxine sodium |
Dosage Form | Tablet |
Route | Oral |
Strength | 0.05mg **see current annual edition, 1.8 description of special situations, levothyroxine sodium; 0.112mg **see current annual edition, 1.8 description of special situations, levothyroxine sodium; 0.2mg **see current annual edition, 1.8 description of spe |
Market Status | Prescription |
Company | Lloyd |
3 of 8 | |
---|---|
Drug Name | Levothyroxine sodium |
Active Ingredient | Levothyroxine sodium |
Dosage Form | Tablet; Powder; Injectable |
Route | injection; Oral; Intravenous |
Strength | 0.05mg **see current annual edition, 1.8 description of special situations, levothyroxine sodium; 200mcg/vial; 0.112mg **see current annual edition, 1.8 description of special situations, levothyroxine sodium; 0.2mg **see current annual edition, 1.8 descr |
Market Status | Prescription |
Company | Fresenius Kabi Usa; Mylan |
4 of 8 | |
---|---|
Drug Name | Levoxyl |
Drug Label | LEVOXYL (levothyroxine sodium tablets, USP) contain synthetic crystalline L-3,3,5,5-tetraiodothyronine sodium salt [levothyroxine (T4) sodium]. Synthetic T4 is identical to that produced in the human thyroid gland. Levothyroxine (T4) sodiu... |
Active Ingredient | Levothyroxine sodium |
Dosage Form | Tablet |
Route | Oral |
Strength | 0.05mg **see current annual edition, 1.8 description of special situations, levothyroxine sodium; 0.112mg **see current annual edition, 1.8 description of special situations, levothyroxine sodium; 0.2mg **see current annual edition, 1.8 description of spe |
Market Status | Prescription |
Company | King Pharms R And D |
5 of 8 | |
---|---|
Drug Name | Levo-t |
Drug Label | Levothyroxine sodium tablets, USP contains synthetic crystalline L-3,3',5,5'-tetraiodothyronine sodium salt [levothyroxine (T4) sodium]. Synthetic T4 is identical to that produced in the human thyroid gland.Levothyroxine (T4) sodium has an empir |
Active Ingredient | Levothyroxine sodium |
Dosage Form | Tablet |
Route | Oral |
Strength | 0.05mg **see current annual edition, 1.8 description of special situations, levothyroxine sodium; 0.112mg **see current annual edition, 1.8 description of special situations, levothyroxine sodium; 0.2mg **see current annual edition, 1.8 description of spe |
Market Status | Prescription |
Company | Alara Pharm |
6 of 8 | |
---|---|
Drug Name | Levothroid |
PubMed Health | Thyroid Supplement (By mouth) |
Drug Classes | Diagnostic Agent, Thyroid Function, Thyroid Supplement |
Drug Label | LEVOTHROID (levothyroxine sodium tablets, USP) contains synthetic crystalline L-3,3',5,5'-tetraiodothyronine sodium salt [levothyroxine (T4) sodium]. Synthetic T4 is identical to that produced in the human thyroid gland. Levothyroxine (T4) sodiu |
Active Ingredient | Levothyroxine sodium |
Dosage Form | Tablet |
Route | Oral |
Strength | 0.05mg **see current annual edition, 1.8 description of special situations, levothyroxine sodium; 0.112mg **see current annual edition, 1.8 description of special situations, levothyroxine sodium; 0.2mg **see current annual edition, 1.8 description of spe |
Market Status | Prescription |
Company | Lloyd |
7 of 8 | |
---|---|
Drug Name | Levothyroxine sodium |
Active Ingredient | Levothyroxine sodium |
Dosage Form | Tablet; Powder; Injectable |
Route | injection; Oral; Intravenous |
Strength | 0.05mg **see current annual edition, 1.8 description of special situations, levothyroxine sodium; 200mcg/vial; 0.112mg **see current annual edition, 1.8 description of special situations, levothyroxine sodium; 0.2mg **see current annual edition, 1.8 descr |
Market Status | Prescription |
Company | Fresenius Kabi Usa; Mylan |
8 of 8 | |
---|---|
Drug Name | Levoxyl |
Drug Label | LEVOXYL (levothyroxine sodium tablets, USP) contain synthetic crystalline L-3,3,5,5-tetraiodothyronine sodium salt [levothyroxine (T4) sodium]. Synthetic T4 is identical to that produced in the human thyroid gland. Levothyroxine (T4) sodiu... |
Active Ingredient | Levothyroxine sodium |
Dosage Form | Tablet |
Route | Oral |
Strength | 0.05mg **see current annual edition, 1.8 description of special situations, levothyroxine sodium; 0.112mg **see current annual edition, 1.8 description of special situations, levothyroxine sodium; 0.2mg **see current annual edition, 1.8 description of spe |
Market Status | Prescription |
Company | King Pharms R And D |
H - Systemic hormonal preparations, excl. sex hormones and insulins
H03 - Thyroid therapy
H03A - Thyroid preparations
H03AA - Thyroid hormones
H03AA01 - Levothyroxine sodium
Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
Fareva is a one-stop-shop for API/HPAPI, OSD & Sterile products, is USFDA, EMA and PMDA-inspected and has multiple NDA & ANDA filings.
GDUFA
DMF Review : Reviewed
Rev. Date : 2014-06-23
Pay. Date : 2013-09-26
DMF Number : 24402
Submission : 2011-10-20
Status : Active
Type : II
NDC Package Code : 46014-1013
Start Marketing Date : 2011-10-20
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Bioiberica is a global life science company committed to improving the health & wellbeing of people, animals & plants.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 29526
Submission : 2015-06-29
Status : Active
Type : II
GDUFA
DMF Review : Reviewed
Rev. Date : 2013-01-15
Pay. Date : 2012-12-21
DMF Number : 4789
Submission : 1983-01-06
Status : Active
Type : II
Certificate Number : CEP 1998-141 - Rev 11
Issue Date : 2023-09-26
Type : Chemical
Substance Number : 401
Status : Valid
Registration Number : 217MF10456
Registrant's Address : Biochemiesstrasse 10, 6250 Kundl, Austria
Initial Date of Registration : 2005-08-24
Latest Date of Registration : --
NDC Package Code : 43858-410
Start Marketing Date : 2010-02-01
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (10kg/10kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : Reviewed
Rev. Date : 2013-01-30
Pay. Date : 2013-01-15
DMF Number : 14715
Submission : 2000-02-01
Status : Active
Type : II
Certificate Number : R1-CEP 1998-048 - Rev 06
Issue Date : 2023-07-05
Type : Chemical
Substance Number : 401
Status : Valid
Registration Number : 221MF10168
Registrant's Address : Am Kraftwerk 6, D-66450 Bexbach, Germany
Initial Date of Registration : 2009-07-30
Latest Date of Registration : --
NDC Package Code : 67891-001
Start Marketing Date : 2003-04-18
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
Registrant Name : Samnam Pharmaceutical Co., Ltd.
Registration Date : 2020-01-10
Registration Number : 20181023-209-J-104(3)
Manufacturer Name : Peptido GmbH
Manufacturer Address : Am Kraftwerk 6, 66450 Bexbach, Germany
GDUFA
DMF Review : Reviewed
Rev. Date : 2021-10-12
Pay. Date : 2021-08-06
DMF Number : 34044
Submission : 2019-08-05
Status : Active
Type : II
Certificate Number : CEP 2023-295 - Rev 00
Issue Date : 2023-12-11
Type : Chemical
Substance Number : 401
Status : Valid
Date of Issue : 2022-09-19
Valid Till : 2025-07-02
Written Confirmation Number : WC-0119
Address of the Firm :
NDC Package Code : 72761-026
Start Marketing Date : 2023-12-15
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : Reviewed
Rev. Date : 2015-07-10
Pay. Date : 2015-05-05
DMF Number : 29098
Submission : 2015-03-14
Status : Active
Type : II
Certificate Number : R1-CEP 2016-280 - Rev 01
Issue Date : 2023-05-26
Type : Chemical
Substance Number : 401
Status : Valid
Date of Issue : 2021-02-26
Valid Till : 2023-06-22
Written Confirmation Number : WC-0404A3
Address of the Firm :
NDC Package Code : 69575-4001
Start Marketing Date : 2015-11-24
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (20kg/20kg)
Marketing Category : BULK INGREDIENT
Registrant Name : Aging Life Science Co., Ltd.
Registration Date : 2020-11-25
Registration Number : 20201125-209-J-789
Manufacturer Name : Azico Biophore India Private Limited
Manufacturer Address : Plot Number 40/A, Sy. No. 13,15,16,51,52 & 182, JN.Pharma city, Thanam(V), Anakapalli District 531021, Andhra Pradesh, India
Fareva is a one-stop-shop for API/HPAPI, OSD & Sterile products, is USFDA, EMA and PMDA-inspected and has multiple NDA & ANDA filings.
GDUFA
DMF Review : Complete
Rev. Date : 2014-06-23
Pay. Date : 2013-09-26
DMF Number : 24402
Submission : 2011-10-20
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 25818
Submission : 2012-02-20
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 30113
Submission : 2016-03-01
Status : Inactive
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2015-07-10
Pay. Date : 2015-05-05
DMF Number : 29098
Submission : 2015-03-14
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2015-09-25
Pay. Date : 2015-08-17
DMF Number : 29550
Submission : 2015-07-27
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2016-04-13
Pay. Date : 2016-03-18
DMF Number : 30376
Submission : 2016-03-22
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2013-01-30
Pay. Date : 2013-01-15
DMF Number : 14715
Submission : 2000-02-01
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 14256
Submission : 1999-06-29
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 29526
Submission : 2015-06-29
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2013-01-15
Pay. Date : 2012-12-21
DMF Number : 4789
Submission : 1983-01-06
Status : Active
Type : II
Levothyroxine sodium, LIM code
Certificate Number : CEP 2023-295 - Rev 00
Status : Valid
Issue Date : 2023-12-11
Type : Chemical
Substance Number : 401
Certificate Number : R0-CEP 2019-190 - Rev 01
Status : Valid
Issue Date : 2023-05-31
Type : Chemical
Substance Number : 401
Certificate Number : R1-CEP 2016-280 - Rev 01
Status : Valid
Issue Date : 2023-05-26
Type : Chemical
Substance Number : 401
Levothyroxine sodium, Product code 083508 and product code 083510
Certificate Number : R1-CEP 2010-011 - Rev 01
Status : Valid
Issue Date : 2017-03-06
Type : Chemical
Substance Number : 401
Levothyroxine sodium, Micronised
Certificate Number : CEP 2017-048 - Rev 01
Status : Valid
Issue Date : 2023-12-05
Type : Chemical
Substance Number : 401
Certificate Number : R1-CEP 2017-040 - Rev 00
Status : Valid
Issue Date : 2023-04-03
Type : Chemical
Substance Number : 401
Certificate Number : CEP 2023-227 - Rev 00
Status : Valid
Issue Date : 2024-02-01
Type : Chemical
Substance Number : 401
Certificate Number : R1-CEP 1998-048 - Rev 06
Status : Valid
Issue Date : 2023-07-05
Type : Chemical
Substance Number : 401
Levothyroxine sodium, Code 460 187 - Code 460 132
Certificate Number : CEP 1998-141 - Rev 11
Status : Valid
Issue Date : 2023-09-26
Type : Chemical
Substance Number : 401
Certificate Number : CEP 2011-315 - Rev 02
Status : Valid
Issue Date : 2023-11-08
Type : Chemical
Substance Number : 401
Registrant Name : Aging Life Science Co., Ltd.
Registration Date : 2020-11-25
Registration Number : 20201125-209-J-789
Manufacturer Name : Azico Biophore India Private...
Manufacturer Address : Plot Number 40/A, Sy. No. 13,15,16,51,52 & 182, JN.Pharma city, Thanam(V), Anakapalli...
Registrant Name : Wooshin Labotech Co., Ltd.
Registration Date : 2019-12-03
Registration Number : 20181023-209-J-104(2)
Manufacturer Name : Peptido GmbH
Manufacturer Address : Am Kraftwerk 6, 66450 Bexbach, Germany
Registrant Name : Samoh Pharmaceutical Co., Ltd.
Registration Date : 2018-10-23
Registration Number : 20181023-209-J-104
Manufacturer Name : Peptido GmbH
Manufacturer Address : Am Kraftwerk 6, 66450 Bexbach, Germany
Registrant Name : Samnam Pharmaceutical Co., Ltd.
Registration Date : 2020-01-10
Registration Number : 20181023-209-J-104(3)
Manufacturer Name : Peptido GmbH
Manufacturer Address : Am Kraftwerk 6, 66450 Bexbach, Germany
Registrant Name : Bukwang Pharmaceutical Co., Ltd.
Registration Date : 2019-02-18
Registration Number : 20181023-209-J-104(1)
Manufacturer Name : Peptido GmbH
Manufacturer Address : Am Kraftwerk 6, 66450 Bexbach, Germany
NDC Package Code : 68513-7155
Start Marketing Date : 2023-06-02
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Fareva is a one-stop-shop for API/HPAPI, OSD & Sterile products, is USFDA, EMA and PMDA-inspected and has multiple NDA & ANDA filings.
NDC Package Code : 46014-1013
Start Marketing Date : 2011-10-20
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Fareva is a one-stop-shop for API/HPAPI, OSD & Sterile products, is USFDA, EMA and PMDA-inspected and has multiple NDA & ANDA filings.
NDC Package Code : 46014-1083
Start Marketing Date : 2011-11-18
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 69575-4001
Start Marketing Date : 2015-11-24
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (20kg/20kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 48087-0140
Start Marketing Date : 2018-12-21
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 51552-1171
Start Marketing Date : 2004-09-01
End Marketing Date : 2026-08-06
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 62991-1709
Start Marketing Date : 2009-05-24
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 57297-977
Start Marketing Date : 2019-12-05
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 38779-1657
Start Marketing Date : 2012-12-13
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 54893-0125
Start Marketing Date : 2023-09-29
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Regulatory Info :
Registration Country : Sweden
levothyroxine sodium (hydrate)
Brand Name : Eltroxin
Dosage Form : TABLET
Dosage Strength : 125 MICROGRAMS
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Sweden
Regulatory Info :
Registration Country : Sweden
levothyroxine sodium (hydrate)
Brand Name : Eltroxin
Dosage Form : TABLET
Dosage Strength : 150 MICROGRAM
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Sweden
Regulatory Info :
Registration Country : Sweden
levothyroxine sodium (hydrate)
Brand Name : Eltroxin
Dosage Form : TABLET
Dosage Strength : 75 MICROGRAMS
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Sweden
Regulatory Info :
Registration Country : Sweden
levothyroxine sodium (hydrate)
Brand Name : Eltroxin
Dosage Form : TABLET
Dosage Strength : 100 MICROGRAMS
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Sweden
Regulatory Info :
Registration Country : Sweden
levothyroxine sodium (hydrate)
Brand Name : Eltroxin
Dosage Form : TABLET
Dosage Strength : 175 MICROGRAMS
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Sweden
Regulatory Info :
Registration Country : Sweden
levothyroxine sodium (hydrate)
Brand Name : Eltroxin
Dosage Form : TABLET
Dosage Strength : 200 MICROGRAM
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Sweden
Regulatory Info :
Registration Country : Sweden
levothyroxine sodium (hydrate)
Brand Name : Eltroxin
Dosage Form : TABLET
Dosage Strength : 50 G
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Sweden
Regulatory Info :
Registration Country : Sweden
levothyroxine sodium (hydrate)
Brand Name : Eltroxin
Dosage Form : TABLET
Dosage Strength : 25 MICROGRAMS
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Sweden
Regulatory Info :
Registration Country : Ukraine
Brand Name : L-Thyroxine-Farmak
Dosage Form : Tablet
Dosage Strength : 100MCG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Ukraine
Regulatory Info :
Registration Country : Switzerland
Brand Name : Tirosint Solution
Dosage Form : Sol
Dosage Strength : 25mcg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Switzerland
Regulatory Info : Prescription
Registration Country : Canada
Brand Name : ELTROXIN
Dosage Form : TABLET
Dosage Strength : 50MCG
Packaging : 500
Approval Date :
Application Number : 2213192
Regulatory Info : Prescription
Registration Country : Canada
Regulatory Info : Prescription
Registration Country : Canada
Brand Name : ELTROXIN
Dosage Form : TABLET
Dosage Strength : 100MCG
Packaging : 500
Approval Date :
Application Number : 2213206
Regulatory Info : Prescription
Registration Country : Canada
Regulatory Info : Prescription
Registration Country : Canada
Brand Name : ELTROXIN
Dosage Form : TABLET
Dosage Strength : 150MCG
Packaging : 500
Approval Date :
Application Number : 2213214
Regulatory Info : Prescription
Registration Country : Canada
Regulatory Info : Prescription
Registration Country : Canada
Brand Name : ELTROXIN
Dosage Form : TABLET
Dosage Strength : 200MCG
Packaging : 500
Approval Date :
Application Number : 2213222
Regulatory Info : Prescription
Registration Country : Canada
Regulatory Info : Prescription
Registration Country : Canada
Brand Name : SYNTHROID
Dosage Form : TABLET
Dosage Strength : 112MCG
Packaging : 90/1000
Approval Date :
Application Number : 2171228
Regulatory Info : Prescription
Registration Country : Canada
Regulatory Info : Prescription
Registration Country : Canada
Brand Name : SYNTHROID
Dosage Form : TABLET
Dosage Strength : 200MCG
Packaging : 90/1000
Approval Date :
Application Number : 2172143
Regulatory Info : Prescription
Registration Country : Canada
Regulatory Info : Prescription
Registration Country : Canada
Brand Name : SYNTHROID
Dosage Form : TABLET
Dosage Strength : 150MCG
Packaging : 90/1000
Approval Date :
Application Number : 2172127
Regulatory Info : Prescription
Registration Country : Canada
Regulatory Info : Prescription
Registration Country : Canada
Brand Name : THYRO-TABS CANINE
Dosage Form : TABLET
Dosage Strength : 0.4MG
Packaging : 180
Approval Date :
Application Number : 2231024
Regulatory Info : Prescription
Registration Country : Canada
Regulatory Info : Prescription
Registration Country : Canada
Brand Name : THYRO-TABS CANINE
Dosage Form : TABLET
Dosage Strength : 0.8MG
Packaging : 180
Approval Date :
Application Number : 2231028
Regulatory Info : Prescription
Registration Country : Canada
Regulatory Info : Prescription
Registration Country : Canada
Brand Name : LEVOTHYROXINE SODIUM FOR INJECTION
Dosage Form : POWDER FOR SOLUTION
Dosage Strength : 200MCG/VIAL
Packaging : 10ML
Approval Date :
Application Number : 2461714
Regulatory Info : Prescription
Registration Country : Canada
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Regulatory Info :
Registration Country : Australia
Brand Name : Eltroxin
Dosage Form :
Dosage Strength :
Packaging : 200
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Australia
Regulatory Info :
Registration Country : Australia
Brand Name : Oroxine
Dosage Form :
Dosage Strength :
Packaging : 200
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Australia
Regulatory Info :
Registration Country : Australia
Brand Name : Eltroxin
Dosage Form :
Dosage Strength :
Packaging : 200
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Australia
Regulatory Info :
Registration Country : Australia
Brand Name : Oroxine
Dosage Form :
Dosage Strength :
Packaging : 200
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Australia
Regulatory Info :
Registration Country : Australia
Brand Name : Eutroxsig
Dosage Form :
Dosage Strength :
Packaging : 200
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Australia
Regulatory Info :
Registration Country : Australia
Brand Name : Eltroxin
Dosage Form :
Dosage Strength :
Packaging : 200
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Australia
Regulatory Info :
Registration Country : Australia
Brand Name : Oroxine
Dosage Form :
Dosage Strength :
Packaging : 200
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Australia
Regulatory Info :
Registration Country : Australia
Brand Name : Eutroxsig
Dosage Form :
Dosage Strength :
Packaging : 200
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Australia
Regulatory Info :
Registration Country : Australia
Brand Name : Eltroxin
Dosage Form :
Dosage Strength :
Packaging : 200
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Australia
Regulatory Info :
Registration Country : Australia
Brand Name : Oroxine
Dosage Form :
Dosage Strength :
Packaging : 200
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Australia
Regulatory Info : Originator
Registration Country : South Africa
Brand Name : Diotroxin
Dosage Form : TAB
Dosage Strength : 90mcg
Packaging : 100X1mcg
Approval Date :
Application Number :
Regulatory Info : Originator
Registration Country : South Africa
Regulatory Info : Originator
Registration Country : South Africa
Brand Name : Eltroxin 50µg
Dosage Form : TAB
Dosage Strength : 50µg
Packaging : 100X1µg
Approval Date :
Application Number :
Regulatory Info : Originator
Registration Country : South Africa
Regulatory Info : Originator
Registration Country : South Africa
Brand Name : Eltroxin 100µg
Dosage Form : TAB
Dosage Strength : 100µg
Packaging : 100X1µg
Approval Date :
Application Number :
Regulatory Info : Originator
Registration Country : South Africa
Regulatory Info : Originator
Registration Country : South Africa
Brand Name : Eltroxin New Formulation 25µg
Dosage Form : TAB
Dosage Strength : 25µg
Packaging : 30X1µg
Approval Date :
Application Number :
Regulatory Info : Originator
Registration Country : South Africa
Regulatory Info : Originator
Registration Country : South Africa
Brand Name : Eltroxin New Formulation 50µg
Dosage Form : TAB
Dosage Strength : 50µg
Packaging : 30X1µg
Approval Date :
Application Number :
Regulatory Info : Originator
Registration Country : South Africa
Regulatory Info : Originator
Registration Country : South Africa
Brand Name : Eltroxin New Formulation 75µg
Dosage Form : TAB
Dosage Strength : 75µg
Packaging : 30X1µg
Approval Date :
Application Number :
Regulatory Info : Originator
Registration Country : South Africa
Regulatory Info : Originator
Registration Country : South Africa
Brand Name : Eltroxin New Formulation 100µg
Dosage Form : TAB
Dosage Strength : 100µg
Packaging : 30X1µg
Approval Date :
Application Number :
Regulatory Info : Originator
Registration Country : South Africa
Regulatory Info : Originator
Registration Country : South Africa
Brand Name : Eltroxin New Formulation 200µg
Dosage Form : TAB
Dosage Strength : 200µg
Packaging : 30X1µg
Approval Date :
Application Number :
Regulatory Info : Originator
Registration Country : South Africa
Regulatory Info : Originator
Registration Country : South Africa
Brand Name : Synthroid 50 µg
Dosage Form : TAB
Dosage Strength : 50µg
Packaging : 30X1µg
Approval Date :
Application Number :
Regulatory Info : Originator
Registration Country : South Africa
Regulatory Info : Originator
Registration Country : South Africa
Brand Name : Synthroid 112 µg
Dosage Form : TAB
Dosage Strength : 112µg
Packaging : 90X1µg
Approval Date :
Application Number :
Regulatory Info : Originator
Registration Country : South Africa
DRUG PRODUCT COMPOSITIONS
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
Patents & EXCLUSIVITIES
REF. STANDARDS & IMPURITIES
ANALYTICAL
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?